Actus Biotech (Convoy and Endurx)

Convoy’s technology platform focuses on solving major unmet needs in aesthetics and pharmaceutical markets by creating novel topical products that are more effective, safer and easier to use; EnduRx is developing therapeutics that specifically target diseased tissue, with the front-line program being focused on the development of a targeted nanosystem for the treatment of Glioblastoma Multiforme (GBM).

Focus area
Graduation date
Commencement date